Jen Herbach
founderYC
Jen Herbach is the CEO of Adventris Pharmaceuticals. She has more than a decade of biotech industry experience bringing novel oncology drugs to market, across companies including Onyx/Amgen, InterMune/Genentech, Exelixis, and Amunix. She holds an MBA from Harvard Business School and a Masters from the University of Cambridge.
1
product
Products · 1
Worked alongside
Roles are derived from products, launches and repositories we track — not from self-description.